Diquas

Diquas Adverse Reactions

diquafosol

Manufacturer:

Santen

Marketer:

Meiji
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Adverse Reactions
Adverse drug reactions (including abnormal changes in laboratory test values) were reported in 155 of 655 patients (23.7%) in clinical trials conducted in Japan before approval. The Major adverse reactions were eye irritation in 44 patients (6.7%), eye discharge in 31 patients (4.7%), conjunctival hyperaemia in 24 patients (3.7%), eye pain in 18 patients (2.7%), eye itching in 16 patients (2.4%), foreign body sensation in eyes in 14 patients (2.1%) and ocular discomfort in 7 patients (1.1%), etc.
Adverse reactions were reported in 202 of 3,196 patients (6.3%) in post marketing observational study in Japan. The major adverse reaction were eye irritation in 30 patients (0.9%), eye discharge in 30 patients (0.9%), eye pain in 22 patients (0.7%), lacrimation increased in 20 patients (0.6%) and blepharitis in 19 patients (0.6%), etc.
If an adverse drug reaction is observed, appropriate measures including discontinuing administration should be taken. (See table.)


Click on icon to see table/diagram/image

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in